Logo
Menu
  • Who We Are
  • How We Invest
  • Our Portfolio
    • Abzena
    • Ixlayer
    • Kiniciti
    • PathAI
  • Blog
  • Careers
  • Contact
What we’ve learned from COVID-19

What we’ve learned from COVID-19

by Biospring | Apr 26, 2022 | Amazon, Biospring Partners, CIC Health, COVID-19, Health Care, Maulik Majmudar, Rodrigo Martinez, Telehealth, Vaccines

We recently hosted a discussion with Dr. Maulik Majmudar, Cardiologist and Principal Medical Officer at Amazon and Rodrigo Martinez, Chief Marketing and Experience Officer at CIC Health. Maulik and Rodrigo shared their unique perspective on how healthcare has changed...
Vaccines, Return to Work & the Economy

Vaccines, Return to Work & the Economy

by Biospring | Apr 26, 2022 | Astrazeneca, Biospring Partners, COVID-19, Economy, Jay Bradner, Katie Burke, Novartis, Oxford, Peter B. Henry, Return to work, Sir John Bell, Vaccines

Last December, we hosted a discussion with industry leaders on COVID-19 and Vaccines, Return-to-Work, and the Economy. We were delighted to host Dr. Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Biospring’s advisors Sir...

Recent Posts

  • Biospring Partners Welcomes Industry Executives To Its Advisory Board
  • Biomanufacturing: A Growing Field
  • Interview with Zach Weinberg
  • Driving Drug Development with Data Science
  • Proteomics 101

Recent Comments

No comments to show.

Newsletter

Thank you for subscribing!

Subscribe